Brief: Alembic Pharmaceuticals Got One USFDA Product Approval (Tentative) During Qtr Ended March 31
April 1 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* RECEIVED ONE US FOOD & DRUG ADMINISTRATION (USFDA) PRODUCT
APPROVAL (TENTATIVE) DURING QUARTER ENDED MARCH 31
Source text for Eikon: ID:nBSEbFg5rv
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand